• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493941812220
Medical Device Problem Code Failure to Advance (2524)
Health Effect - Clinical Code Vascular Dissection (3160)
Date of Event 05/16/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that vessel dissection occurred.The target lesion was located in a severely calcified coronary artery.Two synergy xd drug-eluting stents, a 2.25 x 12mm and a 2.25 x 28mm, were advanced for treatment.The devices had difficulty crossing the lesion and dissection occurred.The patient was flown out for coronary artery bypass graft surgery.
 
Event or Problem Description
It was reported that vessel dissection occurred.The target lesion was located in a severely calcified coronary artery.Two synergy xd drug-eluting stents, a 2.25 x 12mm and a 2.25 x 28mm, were advanced for treatment.The devices had difficulty crossing the lesion and dissection occurred.The patient was flown out for coronary artery bypass graft surgery.It was further reported that the 70% stenosed target lesion was located in the moderately tortuous and severely calcified left anterior descending artery.The dissection was noticed immediately and was treated with long balloon inflation and stenting with a smaller stent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key14552233
Report Number2134265-2022-06078
Device Sequence Number6502824
Product Code NIQ
UDI-Device Identifier08714729980711
UDI-Public08714729980711
Combination Product (Y/N)Y
Initial Reporter StateCO
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/09/2023
Device Model NumberH7493941812220
Device Lot Number0028443989
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 05/20/2022
Supplement Date Received by Manufacturer05/31/2022
Initial Report FDA Received Date05/31/2022
Supplement Report FDA Received Date06/14/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured11/09/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Required Intervention;
Patient SexUnknown
-
-